Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:fluorobenzenes
go back to main search page
Accession:CHEBI:35496 term browser browse the term
Definition:Any fluoroarene that is a benzene or a substituted benzene carrying at least one fluoro group.


show annotations for term's descendants           Sort by:
 
1-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases chemical synthesis
increases glucuronidation
multiple interactions
increases abundance		 ISO CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam
CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam
[[3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[5-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[6-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[6-methylflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[7-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[artemetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[beta-Naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[eupatilin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[sinensetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam] which results in increased abundance of 1-hydroxymethylmidazolam glucuronide; [CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased abundance of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [Ketoconazole results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of 1-hydroxymethylmidazolam; [L 754394 results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of 1-hydroxymethylmidazolam; acacetin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Apigenin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 1-hydroxymethylmidazolam]; diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; erdafitinib inhibits the reaction [[CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; flavanone promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; flavone promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; galangin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased abundance of 1-hydroxymethylmidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; NADP deficiency inhibits the reaction [erdafitinib inhibits the reaction [[CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]]; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Rifampin promotes the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Troleandomycin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Verapamil inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]		 CTD PMID:10997946 PMID:12401345 PMID:12695342 PMID:18191104 PMID:20233841 More... NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis
multiple interactions		 ISO CYP3A5 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam
[CYP3A5 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; erdafitinib inhibits the reaction [[CYP3A5 protein results in increased hydroxylation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]		 CTD PMID:18191104 PMID:26958860 PMID:34189909 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
G Tspo translocator protein affects binding EXP 1-hydroxymethylmidazolam binds to TSPO protein; 1-hydroxymethylmidazolam metabolite binds to TSPO protein CTD PMID:7603229 NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450 		JBrowse link
1-hydroxymidazolam beta-D-glucuronide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam] which results in increased abundance of 1-hydroxymethylmidazolam glucuronide CTD PMID:27485346 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
4-hydroxymidazolam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases chemical synthesis
multiple interactions		 ISO CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam
[CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased abundance of 4-hydroxymidazolam; [CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam; acacetin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; Apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 4-hydroxymidazolam]; diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; flavanone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; flavone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; galangin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Troleandomycin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]		 CTD PMID:12695342 PMID:18191104 PMID:21053930 PMID:27485346 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases chemical synthesis
multiple interactions		 ISO CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam
diosmetin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam]		 CTD PMID:18191104 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
amperozide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions ISO amperozide inhibits the reaction [KCNH2 protein results in increased transport of Thallium] CTD PMID:19583963 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
atorvastatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cdh1 cadherin 1 increases expression ISO atorvastatin co-treated with N-nitrosodiethylamine increases expression of Cdh1 mRNA in liver RGD PMID:25319454 RGD:152995431 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 decreases expression ISO atorvastatin co-treated with N-nitrosodiethylamine decreases expression of Slco1b2 mRNA in liver RGD PMID:25319454 RGD:152995431 NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981 		JBrowse link
azaperone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Azaperone results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
bicalutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aamp angio-associated, migratory cell protein increases expression ISO bicalutamide results in increased expression of AAMP mRNA CTD PMID:16631469 NCBI chr 9:75,863,382...75,869,188
Ensembl chr 9:75,863,389...75,868,547 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO bicalutamide results in decreased activity of ABCB11 protein CTD PMID:28437613 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 decreases activity ISO bicalutamide results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202 		JBrowse link
G Acp3 acid phosphatase 3 decreases expression ISO bicalutamide results in decreased expression of ACP3 mRNA CTD PMID:15638997 NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO bicalutamide results in increased expression of ACSL1 mRNA CTD PMID:15790403 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] CTD PMID:17342749 NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917 		JBrowse link
G Adrb2 adrenoceptor beta 2 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of ADRB2 mRNA; bicalutamide results in decreased expression of ADRB2 protein
bicalutamide inhibits the reaction [Triiodothyronine results in increased expression of ADRB2 protein]		 CTD PMID:18454446 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512 		JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member increases expression ISO bicalutamide results in increased expression of AGR2 mRNA CTD PMID:15638997 NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of AKT1 protein] CTD PMID:17325745 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA] CTD PMID:17526768 NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 increases expression ISO bicalutamide results in increased expression of ALDH3A2 mRNA CTD PMID:15638997 NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO bicalutamide results in decreased expression of AMACR mRNA CTD PMID:15638997 NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255 		JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 increases expression ISO bicalutamide results in increased expression of AMD1 mRNA CTD PMID:15790403 NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476 		JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 increases expression ISO bicalutamide results in increased expression of ANKIB1 mRNA CTD PMID:16631469 NCBI chr 4:30,333,678...30,457,781
Ensembl chr 4:30,333,677...30,457,781 		JBrowse link
G Ar androgen receptor decreases response to substance
decreases expression
multiple interactions
increases expression
decreases activity
affects binding
affects response to substance
affects localization		 ISO
EXP		 AR gene mutant form results in decreased susceptibility to bicalutamide; AR protein alternative form results in decreased susceptibility to bicalutamide
bicalutamide results in decreased expression of AR protein
bicalutamide binds to and results in decreased activity of AR protein; bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]]
bicalutamide results in increased localization of and results in increased activity of AR protein
bicalutamide results in increased expression of AR; bicalutamide results in increased expression of AR protein
bicalutamide results in decreased expression of AR; bicalutamide results in decreased expression of AR mRNA
bicalutamide results in decreased activity of AR protein
[bicalutamide binds to AR protein] which binds to KLK3 promoter; bicalutamide binds to AR protein
AR protein affects the susceptibility to bicalutamide
[Azacitidine analog results in increased expression of AR protein] which results in increased susceptibility to bicalutamide; [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; [bicalutamide co-treated with Testosterone] affects the expression of and results in decreased activity of AR protein; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of and affects the localization of AR protein alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR mRNA alternative form; [bicalutamide results in decreased susceptibility to bicalutamide] which results in increased expression of AR protein; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB1 protein]; [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; [Goserelin co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB1 protein binds to KLK3 promoter]]; bicalutamide affects the reaction [beta-hexachlorocyclohexane affects the expression of AR protein]; bicalutamide affects the reaction [Testosterone affects the expression of AR protein]; bicalutamide binds to and affects the localization of and affects the activity of AR protein; bicalutamide binds to and results in decreased activity of AR protein; bicalutamide binds to and results in increased activity of AR protein mutant form; bicalutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [[Dihydrotestosterone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [[Metribolone binds to and results in increased activity of AR protein] which results in increased expression of KLK3 protein]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [AR protein alternative form binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein alternative form promotes the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; bicalutamide inhibits the reaction [AR protein binds to KLK3 promoter]; bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in decreased expression of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone affects the localization of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone binds to AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of AR mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of and results in increased phosphorylation of AR protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Estradiol results in increased activity of AR protein]; bicalutamide inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Flutamide results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein mutant form]; bicalutamide inhibits the reaction [Metribolone results in increased activity of AR protein]; bicalutamide inhibits the reaction [Metribolone results in increased folding of and results in increased stability of AR protein]; bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein]; bicalutamide inhibits the reaction [Sirolimus results in increased activity of AR protein]; bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]; bicalutamide promotes the reaction [AR protein binds to KLK3 promoter]; bicalutamide promotes the reaction [AR protein binds to NCOR2 protein]; bicalutamide promotes the reaction [Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein alternative form]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein]; methoxyacetic acid inhibits the reaction [bicalutamide inhibits the reaction [Testosterone results in increased activity of AR protein]]; mibolerone inhibits the reaction [bicalutamide results in increased expression of AR protein]; Resveratrol promotes the reaction [bicalutamide results in decreased activity of AR protein]
bicalutamide affects the localization of AR protein		 CTD PMID:10053169 PMID:11751618 PMID:11845989 PMID:11956172 PMID:11981028 More... NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Arg1 arginase 1 decreases expression ISO bicalutamide results in decreased expression of ARG1 protein CTD PMID:20711410 NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422 		JBrowse link
G Arg2 arginase 2 increases expression ISO bicalutamide results in increased expression of ARG2 protein CTD PMID:20711410 NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378 		JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 increases expression ISO bicalutamide results in increased expression of ASAP2 mRNA CTD PMID:16631469 NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression
increases expression		 ISO bicalutamide results in decreased expression of ATF3 protein
bicalutamide results in increased expression of ATF3 mRNA		 CTD PMID:15638997 PMID:16516039 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO bicalutamide results in increased expression of ATP5ME mRNA CTD PMID:16631469 NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 increases expression ISO bicalutamide results in increased expression of B4GALT6 mRNA CTD PMID:16631469 NCBI chr18:11,958,382...12,015,247
Ensembl chr18:11,958,390...12,015,247 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO bicalutamide results in decreased expression of BARD1 mRNA CTD PMID:15638997 NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression
increases expression
multiple interactions		 ISO bicalutamide results in decreased expression of BAX
bicalutamide results in increased expression of BAX protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of BAX protein; [Niclosamide co-treated with bicalutamide] results in increased expression of BAX protein; bicalutamide inhibits the reaction [Niclosamide results in decreased expression of BAX protein]		 CTD PMID:11845989 PMID:27132804 PMID:28500234 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bche butyrylcholinesterase decreases expression ISO bicalutamide results in decreased expression of BCHE mRNA CTD PMID:15638997 NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
multiple interactions		 ISO bicalutamide results in increased expression of BCL2
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein]		 CTD PMID:11845989 PMID:28500234 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of BCL2L1 protein
bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein]		 CTD PMID:28500234 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO bicalutamide results in decreased expression of BIRC5 mRNA CTD PMID:15638997 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380 		JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression ISO bicalutamide results in increased expression of BNIP3 mRNA CTD PMID:15790403 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359 		JBrowse link
G Btbd3 BTB domain containing 3 increases expression ISO bicalutamide results in increased expression of BTBD3 mRNA CTD PMID:16631469 NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression ISO bicalutamide results in decreased expression of BUB1B mRNA CTD PMID:15638997 NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO [bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CASP3 protein; bicalutamide results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:15638997 PMID:27132804 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp7 caspase 7 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form] CTD PMID:28500234 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] CTD PMID:16317058 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO bicalutamide results in decreased expression of CCNA2 mRNA CTD PMID:15887248 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO bicalutamide results in decreased expression of CCNB1 mRNA CTD PMID:15887248 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnb1ip1 cyclin B1 interacting protein 1 increases expression ISO bicalutamide results in increased expression of CCNB1IP1 mRNA CTD PMID:15638997 NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression		 ISO Niclosamide promotes the reaction [bicalutamide results in decreased expression of CCND1 protein] CTD PMID:28500234 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO bicalutamide results in increased expression of CCNG2 mRNA CTD PMID:15790403 NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830 		JBrowse link
G Ccpg1 cell cycle progression 1 increases expression ISO bicalutamide results in increased expression of CCPG1 mRNA CTD PMID:15638997 NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430 		JBrowse link
G Cd40 CD40 molecule multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA]] CTD PMID:16317058 NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534 		JBrowse link
G Cd9 CD9 molecule increases expression ISO bicalutamide results in increased expression of CD9 mRNA CTD PMID:15790403 NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression ISO bicalutamide results in decreased expression of CDC20 mRNA CTD PMID:15638997 NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO bicalutamide results in decreased expression of CDC6 mRNA; bicalutamide results in decreased expression of CDC6 protein CTD PMID:15887248 NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011 		JBrowse link
G Cdh1 cadherin 1 affects localization ISO bicalutamide affects the localization of CDH1 protein CTD PMID:17440980 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression ISO bicalutamide results in decreased expression of CDK1 mRNA CTD PMID:15638997 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions		 ISO bicalutamide results in increased expression of CDKN1A; bicalutamide results in increased expression of CDKN1A mRNA; bicalutamide results in increased expression of CDKN1A protein
[bicalutamide co-treated with Curcumin co-treated with Quercetin] results in increased expression of CDKN1A protein		 CTD PMID:11845989 PMID:15638997 PMID:27132804 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO bicalutamide results in increased expression of CDKN1B CTD PMID:11845989 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO bicalutamide results in decreased expression of CDKN2C mRNA CTD PMID:15638997 NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression ISO bicalutamide results in decreased expression of CKS2 mRNA CTD PMID:15638997 NCBI chr17:13,570,611...13,575,770 JBrowse link
G Clgn calmegin increases expression ISO bicalutamide results in increased expression of CLGN mRNA CTD PMID:15638997 NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758 		JBrowse link
G Clu clusterin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of CLU protein] CTD PMID:17148459 PMID:17325745 NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315 		JBrowse link
G Copb2 COPI coat complex subunit beta 2 increases expression ISO bicalutamide results in increased expression of COPB2 mRNA CTD PMID:16631469 NCBI chr 8:99,161,324...99,183,452
Ensembl chr 8:99,161,350...99,185,197 		JBrowse link
G Crebbp CREB binding protein multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in decreased expression of CREBBP protein] CTD PMID:15378487 NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Cubn cubilin decreases expression
multiple interactions		 EXP bicalutamide results in decreased expression of CUBN protein
bicalutamide promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of CUBN protein]		 CTD PMID:35151640 NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP11A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP11A1 protein] CTD PMID:21273442 NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions EXP bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein]; bicalutamide inhibits the reaction [Testosterone results in increased expression of CYP19A1 protein] CTD PMID:21273442 NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity ISO bicalutamide results in decreased activity of CYP1A1 protein CTD PMID:34181028 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA]; bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] CTD PMID:23603339 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO bicalutamide results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions EXP bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]] CTD PMID:20032058 NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of DEPTOR mRNA] CTD PMID:26558456 NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO bicalutamide results in increased expression of DIO3 mRNA CTD PMID:15638997 NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 decreases expression ISO bicalutamide results in decreased expression of DKC1 mRNA CTD PMID:15638997
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO bicalutamide results in increased expression of DNAJB9 mRNA CTD PMID:15638997 NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063 		JBrowse link
G Drd4 dopamine receptor D4 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of DRD4 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]		 CTD PMID:19587329 NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO bicalutamide results in decreased expression of EBP mRNA CTD PMID:15638997 NCBI chr  X:14,299,427...14,305,826
Ensembl chr  X:14,299,448...14,305,826 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to AR protein]]; bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of EGFR protein] CTD PMID:29383186 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:21036700 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984 		JBrowse link
G Eppin epididymal peptidase inhibitor decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of EPPIN mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]		 CTD PMID:19587329 NCBI chr 3:153,312,396...153,319,310
Ensembl chr 3:153,312,396...153,319,310 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO bicalutamide binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO bicalutamide inhibits the reaction [bisphenol A promotes the reaction [EGFR protein binds to ESR2 protein]] CTD PMID:29383186 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Etl4 enhancer trap locus 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of KIAA1217 mRNA] CTD PMID:17624924 NCBI chr17:82,841,075...83,304,868
Ensembl chr17:82,495,041...83,304,715 		JBrowse link
G Etv1 ETS variant transcription factor 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ETV1 mRNA] CTD PMID:28757136 NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775 		JBrowse link
G Ezr ezrin multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of EZR mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of EZR protein] CTD PMID:16873375 NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein] CTD PMID:18801408 NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578 		JBrowse link
G Fgf13 fibroblast growth factor 13 increases expression ISO bicalutamide results in increased expression of FGF13 mRNA CTD PMID:15638997 NCBI chr  X:137,276,498...137,800,056
Ensembl chr  X:137,276,511...137,800,391 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression ISO bicalutamide results in increased expression of FKBP11 mRNA CTD PMID:15638997 NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of FKBP5 mRNA
[Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA		 CTD PMID:28500234 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FOS mRNA]; bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA] CTD PMID:15466214 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO FSHB protein inhibits the reaction [bicalutamide results in decreased expression of DRD4 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of EPPIN protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]; FSHB protein inhibits the reaction [bicalutamide results in decreased expression of RHOX5 protein] CTD PMID:19587329 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO bicalutamide results in increased expression of GADD45A mRNA CTD PMID:15638997 NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115 		JBrowse link
G Gcg glucagon decreases expression ISO bicalutamide results in decreased expression of GCG mRNA CTD PMID:15638997 NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929 		JBrowse link
G Gpc1 glypican 1 decreases expression ISO bicalutamide results in decreased expression of GPC1 mRNA CTD PMID:15638997 NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of GPD1 mRNA
FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein]		 CTD PMID:19587329 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529 		JBrowse link
G Gpnmb glycoprotein nmb increases expression ISO bicalutamide results in increased expression of GPNMB mRNA CTD PMID:15638997 NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A decreases expression ISO bicalutamide results in decreased expression of GPRC5A mRNA CTD PMID:15638997 NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] CTD PMID:16496412 NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633 		JBrowse link
G Gtpbp2 GTP binding protein 2 increases expression ISO bicalutamide results in increased expression of GTPBP2 mRNA CTD PMID:15638997 NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression
multiple interactions		 EXP bicalutamide results in increased expression of HIF1A protein
bicalutamide promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of HIF1A protein]		 CTD PMID:35151640 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hk2 hexokinase 2 increases expression EXP bicalutamide results in increased expression of HK2 protein CTD PMID:35151640 NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530 		JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO bicalutamide results in increased expression of HYOU1 mRNA CTD PMID:15638997 NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]] CTD PMID:16317058 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
increases expression		 ISO [bicalutamide co-treated with Tamoxifen] results in decreased expression of IGF1 protein; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1 mRNA]
bicalutamide results in increased expression of IGF1 mRNA; bicalutamide results in increased expression of IGF1 protein		 CTD PMID:16368782 PMID:16847815 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions
increases expression		 ISO
EXP		 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA]
bicalutamide results in increased expression of IGFBP2 mRNA		 CTD PMID:10604720 PMID:16368782 NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression
decreases secretion
decreases expression		 ISO
EXP		 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 protein
bicalutamide results in increased expression of IGFBP3 mRNA
bicalutamide results in decreased secretion of IGFBP3 protein
bicalutamide results in decreased expression of IGFBP3 mRNA		 CTD PMID:10604720 PMID:16368782 PMID:16847815 NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 increases expression EXP bicalutamide results in increased expression of IGFBP4 mRNA CTD PMID:10604720 NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 increases expression EXP bicalutamide results in increased expression of IGFBP5 mRNA CTD PMID:10604720 NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [IL6 protein results in increased expression of KLK3 mRNA] CTD PMID:11410519 PMID:14532843 PMID:16317058 PMID:19240160 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Kif20a kinesin family member 20A decreases expression ISO bicalutamide results in decreased expression of KIF20A mRNA CTD PMID:15638997 NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 increases expression ISO bicalutamide results in increased expression of LAMP2 mRNA CTD PMID:16631469 NCBI chr  X:117,173,097...117,222,090
Ensembl chr  X:117,057,606...117,260,522 		JBrowse link
G Lamp3 lysosomal-associated membrane protein 3 increases expression ISO bicalutamide results in increased expression of LAMP3 mRNA CTD PMID:15638997 NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784 		JBrowse link
G Lcn2 lipocalin 2 increases expression ISO bicalutamide results in increased expression of LCN2 mRNA CTD PMID:15638997 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095 		JBrowse link
G Ldha lactate dehydrogenase A increases expression EXP bicalutamide results in increased expression of LDHA protein CTD PMID:35151640 NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Ldlr low density lipoprotein receptor affects localization ISO bicalutamide affects the localization of LDLR protein CTD PMID:17440980 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lmnb1 lamin B1 decreases expression ISO bicalutamide results in decreased expression of LMNB1 mRNA CTD PMID:15638997 NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502 		JBrowse link
G LOC102549061 histone H2B type 1-N-like increases expression ISO bicalutamide results in increased expression of H2BC3 mRNA CTD PMID:15790403 NCBI chr17:41,380,058...41,380,685 JBrowse link
G Lrba LPS responsive beige-like anchor protein increases expression ISO bicalutamide results in increased expression of LRBA mRNA CTD PMID:15790403 NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 decreases expression ISO bicalutamide results in decreased expression of MAD2L1 mRNA CTD PMID:15638997 NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470 		JBrowse link
G Man1a1 mannosidase, alpha, class 1A, member 1 increases expression ISO bicalutamide results in increased expression of MAN1A1 mRNA CTD PMID:15638997 NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein CTD PMID:15466214 NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K2 protein CTD PMID:15466214 NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:15466214 PMID:29383186 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK3 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; bicalutamide results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:15466214 PMID:29383186 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 increases expression ISO bicalutamide results in increased expression of MBD2 mRNA CTD PMID:16631469 NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 decreases expression ISO bicalutamide results in decreased expression of MCM2 mRNA CTD PMID:15638997 NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847 		JBrowse link
G Mdk midkine increases expression ISO bicalutamide results in increased expression of MDK mRNA CTD PMID:15638997 NCBI chr 3:77,901,156...77,903,997
Ensembl chr 3:77,901,158...77,903,130 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase multiple interactions ISO bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] CTD PMID:11139396 PMID:17371283 NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876 		JBrowse link
G Mir21 microRNA 21 multiple interactions ISO bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA]; bicalutamide inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] CTD PMID:23052036 PMID:25969534 NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO bicalutamide results in decreased expression of MKI67 mRNA CTD PMID:15638997 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Mme membrane metallo-endopeptidase increases expression ISO bicalutamide results in increased expression of MME mRNA CTD PMID:15790403 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792 		JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO bicalutamide inhibits the reaction [Androgens results in increased expression of MMP13 mRNA] CTD PMID:15138554 NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO bicalutamide inhibits the reaction [Metribolone results in increased expression of MMP2 mRNA] CTD PMID:16888681 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870 		JBrowse link
G Msmb microseminoprotein, beta decreases expression ISO bicalutamide results in decreased expression of MSMB mRNA CTD PMID:33932781 NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
decreases expression		 ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC mRNA; [Niclosamide co-treated with bicalutamide] results in decreased expression of MYC protein; bicalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC mRNA]; Niclosamide inhibits the reaction [bicalutamide results in increased expression of MYC protein]
bicalutamide results in decreased expression of MYC mRNA		 CTD PMID:15638997 PMID:24759320 PMID:28500234 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Myo6 myosin VI increases expression ISO bicalutamide results in increased expression of MYO6 mRNA CTD PMID:15790403 PMID:16631469 NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO bicalutamide inhibits the reaction [AR protein binds to NCOA1 protein] CTD PMID:11981028 NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO [IL6 protein results in increased expression of NCOA2 protein] which results in decreased susceptibility to bicalutamide CTD PMID:19240160 NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451 		JBrowse link
G Ncor2 nuclear receptor co-repressor 2 multiple interactions ISO bicalutamide promotes the reaction [AR protein binds to NCOR2 protein] CTD PMID:11981028 NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319 		JBrowse link
G Nebl nebulette increases expression ISO bicalutamide results in increased expression of NEBL mRNA CTD PMID:15638997 NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210 		JBrowse link
G Nek2 NIMA-related kinase 2 decreases expression ISO bicalutamide results in decreased expression of NEK2 mRNA CTD PMID:15638997 NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051 		JBrowse link
G Niban1 niban apoptosis regulator 1 increases expression ISO bicalutamide results in increased expression of NIBAN1 mRNA CTD PMID:15638997 NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729 		JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions
decreases expression		 ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA; bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]
bicalutamide results in decreased expression of NKX3-1 mRNA		 CTD PMID:11751618 PMID:15638997 PMID:28500234 PMID:29462692 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO bicalutamide binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Nrp1 neuropilin 1 decreases expression ISO bicalutamide results in decreased expression of NRP1 mRNA CTD PMID:15638997 NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633 		JBrowse link
G Nts neurotensin decreases response to substance ISO NTS protein results in decreased susceptibility to bicalutamide CTD PMID:17044078 NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 decreases expression ISO bicalutamide results in decreased expression of NUSAP1 mRNA CTD PMID:15638997 NCBI chr 3:106,603,273...106,633,624
Ensembl chr 3:106,603,289...106,633,624 		JBrowse link
G Osm oncostatin M multiple interactions ISO bicalutamide inhibits the reaction [OSM protein results in increased activity of AR protein] CTD PMID:12114440 NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313 		JBrowse link
G Pa2g4 proliferation-associated 2G4 multiple interactions
increases response to substance		 ISO bicalutamide promotes the reaction [PA2G4 protein binds to KLK3 promoter]
PA2G4 protein results in increased susceptibility to bicalutamide		 CTD PMID:15994225 NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of PARP1 protein modified form] CTD PMID:28500234 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Pbk PDZ binding kinase decreases expression ISO bicalutamide results in decreased expression of PBK mRNA CTD PMID:15638997 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO bicalutamide results in decreased expression of PCNA mRNA CTD PMID:15638997 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Pds5b PDS5 cohesin associated factor B multiple interactions ISO bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN] CTD PMID:15754350 NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596 		JBrowse link
G Pecr peroxisomal trans-2-enoyl-CoA reductase increases expression ISO bicalutamide results in increased expression of PECR mRNA CTD PMID:15638997 NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511 		JBrowse link
G Pfkm phosphofructokinase, muscle decreases expression EXP bicalutamide results in decreased expression of PFKM protein CTD PMID:35151640 NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO bicalutamide binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344 		JBrowse link
G Phb1 prohibitin 1 multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to PHB1 protein]; AR protein promotes the reaction [bicalutamide promotes the reaction [PHB1 protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [PHB1 protein binds to KLK3 promoter]; PHB1 protein promotes the reaction [bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; PHB1 protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042 		JBrowse link
G Pip prolactin induced protein decreases expression
multiple interactions		 ISO bicalutamide results in decreased expression of PIP mRNA
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of PIP mRNA]		 CTD PMID:10402478 NCBI chr 4:70,787,627...70,791,921
Ensembl chr 4:70,787,627...70,791,921 		JBrowse link
G Pklr pyruvate kinase L/R decreases expression EXP bicalutamide results in decreased expression of PKLR protein CTD PMID:35151640 NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO bicalutamide results in decreased expression of PRC1 mRNA CTD PMID:15638997 NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765 		JBrowse link
G Pten phosphatase and tensin homolog multiple interactions
increases activity		 ISO bicalutamide promotes the reaction [PTEN protein results in decreased expression of KLK3 mRNA]
bicalutamide results in increased activity of PTEN protein		 CTD PMID:16637073 NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] CTD PMID:16317058 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 decreases expression ISO bicalutamide results in decreased expression of RACGAP1 mRNA CTD PMID:15638997 NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831 		JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO bicalutamide results in decreased expression of RANBP1 mRNA CTD PMID:15638997 NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838 		JBrowse link
G Rarb retinoic acid receptor, beta increases expression ISO bicalutamide results in increased expression of RARB mRNA CTD PMID:15790403 NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288 		JBrowse link
G Rb1 RB transcriptional corepressor 1 increases phosphorylation ISO bicalutamide results in increased phosphorylation of RB1 protein CTD PMID:17599054 NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302 		JBrowse link
G Rom1 retinal outer segment membrane protein 1 increases expression ISO bicalutamide results in increased expression of ROM1 mRNA CTD PMID:15790403 NCBI chr 1:205,824,050...205,826,058
Ensembl chr 1:205,824,052...205,826,175 		JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6 protein CTD PMID:21036700 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions ISO [bicalutamide co-treated with Testosterone] results in decreased phosphorylation of RPS6KB1 protein CTD PMID:21036700 NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO bicalutamide results in decreased expression of RRM2 mRNA CTD PMID:15638997 NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773 		JBrowse link
G Rxrb retinoid X receptor beta decreases expression ISO bicalutamide results in decreased expression of RXRB CTD PMID:11845989 NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773 		JBrowse link
G Scgb2a1 secretoglobin, family 2A, member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SCGB2A1 mRNA] CTD PMID:16020486 NCBI chr 1:206,497,848...206,501,211
Ensembl chr 1:206,497,849...206,501,211
Ensembl chr 1:206,497,849...206,501,211 		JBrowse link
G Sem1 SEM1 26S proteasome subunit increases expression ISO bicalutamide results in increased expression of SEM1 mRNA CTD PMID:16631469 NCBI chr 4:34,671,848...34,692,005
Ensembl chr 4:34,671,848...34,692,005 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINE1 mRNA]] CTD PMID:16317058 NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions
increases expression
decreases expression		 EXP bicalutamide promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A1 protein]
bicalutamide results in increased expression of SLC2A1 protein
bicalutamide results in decreased expression of SLC2A1 protein		 CTD PMID:35151640 NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression ISO bicalutamide results in increased expression of SLC3A2 mRNA CTD PMID:15638997 NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931 		JBrowse link
G Slc4a4 solute carrier family 4 member 4 decreases expression ISO bicalutamide results in decreased expression of SLC4A4 mRNA CTD PMID:15638997 NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO bicalutamide results in increased expression of SLC7A11 mRNA CTD PMID:15638997 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536 		JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 multiple interactions ISO [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein]; bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]; PHB1 protein promotes the reaction [bicalutamide promotes the reaction [SMARCA4 protein binds to KLK3 promoter]] CTD PMID:18487222 NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975 		JBrowse link
G Snap25 synaptosome associated protein 25 increases expression ISO bicalutamide results in increased expression of SNAP25 mRNA CTD PMID:15790403 NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760 		JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO bicalutamide results in increased expression of SORD mRNA CTD PMID:15790403 NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133 		JBrowse link
G Spint2 serine peptidase inhibitor, Kunitz type, 2 increases expression ISO bicalutamide results in increased expression of SPINT2 mRNA CTD PMID:15790403 NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616 		JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO bicalutamide results in increased expression of SQSTM1 mRNA CTD PMID:15638997 NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 decreases expression ISO bicalutamide results in decreased expression of STIP1 mRNA CTD PMID:15638997 NCBI chr 1:204,209,434...204,228,452
Ensembl chr 1:204,178,932...204,228,476 		JBrowse link
G Tamm41 TAM41 mitochondrial translocator assembly and maintenance homolog increases expression ISO bicalutamide results in increased expression of TAMM41 mRNA CTD PMID:16631469 NCBI chr 4:148,070,388...148,103,728
Ensembl chr 4:148,018,463...148,103,694 		JBrowse link
G Tert telomerase reverse transcriptase decreases activity
decreases expression		 ISO bicalutamide results in decreased activity of TERT protein
bicalutamide results in decreased expression of TERT mRNA		 CTD PMID:15638997 NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561 		JBrowse link
G Thra thyroid hormone receptor alpha multiple interactions ISO bicalutamide binds to and results in increased activity of THRA protein CTD PMID:33049310 NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936 		JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO bicalutamide binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO bicalutamide results in decreased expression of TK1 mRNA CTD PMID:15638997 NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]] CTD PMID:16317058 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of TMEFF2 protein] CTD PMID:23405127 NCBI chr 9:50,445,550...50,733,482
Ensembl chr 9:50,436,079...50,733,475 		JBrowse link
G Tmsb4x thymosin beta 4, X-linked multiple interactions
increases expression		 ISO bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of TMSB4X mRNA]
bicalutamide results in increased expression of TMSB4X mRNA		 CTD PMID:17916567 NCBI chr  X:27,144,677...27,146,667
Ensembl chr  X:27,128,610...27,146,667 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions		 ISO bicalutamide results in increased expression of TP53 protein
bicalutamide inhibits the reaction [bisphenol A results in increased phosphorylation of TP53 protein]		 CTD PMID:15638997 PMID:29383186 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tp53i3 tumor protein p53 inducible protein 3 increases expression ISO bicalutamide results in increased expression of TP53I3 mRNA CTD PMID:15638997 NCBI chr 6:27,818,327...27,827,030 JBrowse link
G Tpd52 tumor protein D52 decreases response to substance ISO TPD52 protein results in decreased susceptibility to bicalutamide CTD PMID:17875733 NCBI chr 2:92,735,246...92,816,079
Ensembl chr 2:92,735,620...92,816,622 		JBrowse link
G Tpx2 TPX2, microtubule nucleation factor decreases expression ISO bicalutamide results in decreased expression of TPX2 mRNA CTD PMID:15638997 NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468 		JBrowse link
G Tram1 translocation associated membrane protein 1 increases expression ISO bicalutamide results in increased expression of TRAM1 mRNA CTD PMID:16631469 NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971 		JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO bicalutamide results in increased expression of TRIB3 mRNA CTD PMID:15638997 NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497 		JBrowse link
G Tyms thymidylate synthetase decreases expression ISO bicalutamide results in decreased expression of TYMS protein CTD PMID:17599054 NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536 		JBrowse link
G Uap1 UDP-N-acetylglucosamine pyrophosphorylase 1 increases expression ISO bicalutamide results in increased expression of UAP1 mRNA CTD PMID:15790403 NCBI chr13:82,342,946...82,377,558
Ensembl chr13:82,342,946...82,377,469 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA CTD PMID:28500234 NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339 		JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 decreases expression ISO bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression ISO bicalutamide results in increased expression of UPP1 mRNA CTD PMID:15638997 NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462 		JBrowse link
G Uxt ubiquitously-expressed, prefoldin-like chaperone affects response to substance ISO UXT protein affects the susceptibility to bicalutamide CTD PMID:19318562 NCBI chr  X:1,126,110...1,138,670
Ensembl chr  X:1,126,162...1,138,663 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA]]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:16317058 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 increases expression ISO bicalutamide results in increased expression of WARS1 mRNA CTD PMID:15638997 NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269 		JBrowse link
G Ythdf3 YTH N(6)-methyladenosine RNA binding protein 3 increases expression ISO bicalutamide results in increased expression of YTHDF3 mRNA CTD PMID:16631469 NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606 		JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression ISO bicalutamide results in increased expression of ZMAT3 mRNA CTD PMID:15638997 NCBI chr 2:115,106,050...115,136,863
Ensembl chr 2:115,106,966...115,136,863 		JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO bicalutamide results in decreased expression of ZWINT mRNA CTD PMID:15638997 NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957 		JBrowse link
bictegravir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 decreases expression ISO bictegravir results in decreased expression of ALDH1A2 mRNA CTD PMID:34515794 NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 increases expression ISO bictegravir results in increased expression of CYP26A1 mRNA CTD PMID:34515794 NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204 		JBrowse link
G Fgf8 fibroblast growth factor 8 increases expression ISO bictegravir results in increased expression of FGF8 mRNA CTD PMID:34515794 NCBI chr 1:244,584,477...244,590,359
Ensembl chr 1:244,584,652...244,590,359 		JBrowse link
G Mixl1 Mix paired-like homeobox 1 increases expression ISO bictegravir results in increased expression of MIXL1 mRNA CTD PMID:34515794 NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065 		JBrowse link
binimetinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [NADP co-treated with binimetinib] results in decreased activity of CYP1A2 protein CTD PMID:33728909 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
brequinar term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Dhodh dihydroorotate dehydrogenase (quinone) multiple interactions
decreases activity		 EXP
ISO		 brequinar inhibits the reaction [DHODH protein results in increased metabolism of 4,5-dihydroorotic acid]; brequinar inhibits the reaction [DHODH protein results in increased metabolism of Quinones]; brequinar inhibits the reaction [DHODH protein results in increased oxidation of 4,5-dihydroorotic acid]
brequinar results in decreased activity of DHODH protein		 CTD PMID:9776318 PMID:9802339 PMID:10658902 NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654 		JBrowse link
cobimetinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bcl2l11 Bcl2-like 11 increases expression
multiple interactions		 ISO cobimetinib results in increased expression of BCL2L11 protein; cobimetinib results in increased expression of BCL2L11 protein alternative form
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased expression of BCL2L11 protein alternative form]; 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased expression of BCL2L11 protein]; [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with cobimetinib] results in decreased phosphorylation of BCL2L11 protein alternative form; cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of BCL2L11 protein alternative form]		 CTD PMID:22084396 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase multiple interactions
increases response to substance		 ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [BRAF protein mutant form results in increased susceptibility to cobimetinib] CTD PMID:22084396 NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions		 ISO cobimetinib results in decreased expression of CCND1 protein
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in decreased expression of CCND1 protein]		 CTD PMID:22084396 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Gpt glutamic--pyruvic transaminase increases secretion EXP cobimetinib results in increased secretion of GPT protein CTD PMID:29655783 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Kras KRAS proto-oncogene, GTPase increases response to substance
multiple interactions		 ISO KRAS protein mutant form results in increased susceptibility to cobimetinib
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [KRAS protein mutant form results in increased susceptibility to cobimetinib]; cobimetinib promotes the reaction [KRAS protein mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine]		 CTD PMID:22084396 NCBI chr 4:178,185,418...178,218,484 JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation ISO cobimetinib results in decreased phosphorylation of MAPK1 protein CTD PMID:22084396 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation ISO cobimetinib results in decreased phosphorylation of MAPK3 protein CTD PMID:22084396 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Nras NRAS proto-oncogene, GTPase increases response to substance ISO NRAS protein mutant form results in increased susceptibility to cobimetinib CTD PMID:22084396 NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases cleavage		 ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased cleavage of PARP1 protein]; cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein] CTD PMID:22084396 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased phosphorylation of RPS6 protein] CTD PMID:22084396 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602 		JBrowse link
dacomitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 multiple interactions
affects metabolic processing		 ISO Quinidine affects the reaction [CYP2D6 protein polymorphism affects the metabolism of dacomitinib] CTD PMID:34936353 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO dacomitinib inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein] CTD PMID:27491023 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
DAPT term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]] CTD PMID:31348943 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein] CTD PMID:31348943 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] CTD PMID:22115781 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of BAX protein CTD PMID:21209419 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein CTD PMID:21209419 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA] CTD PMID:23566955 NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of and results in increased activity of CASP3 protein CTD PMID:21209419 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] CTD PMID:19160421 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester co-treated with 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one] inhibits the reaction [polyhexamethyleneguanidine results in decreased expression of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased secretion of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased cleavage of CDH1 protein] CTD PMID:18791180 PMID:31348943 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Cdh2 cadherin 2 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein] CTD PMID:23876460 NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA] CTD PMID:24223152 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Eno2 enolase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA] CTD PMID:24929042 NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FLT1 protein] CTD PMID:21843347 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein] CTD PMID:25108166 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions
decreases expression		 ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HES1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of HES1 protein		 CTD PMID:19160421 PMID:24223152 PMID:25005833 PMID:25108166 PMID:32041402 NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192 		JBrowse link
G Hey1 hes-related family bHLH transcription factor with YRPW motif 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] CTD PMID:19160421 NCBI chr 2:93,096,706...93,100,316
Ensembl chr 2:93,095,498...93,100,312 		JBrowse link
G Hey2 hes-related family bHLH transcription factor with YRPW motif 2 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HEY2 mRNA]		 CTD PMID:19160421 PMID:32041402 NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of HIF1A protein] CTD PMID:25108166 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of HMGB1 protein] CTD PMID:21843347 NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565 		JBrowse link
G Il10 interleukin 10 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] CTD PMID:24223152 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]		 CTD PMID:21843347 PMID:24223152 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP
ISO		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]		 CTD PMID:21843347 PMID:24223152 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein] CTD PMID:28130038 NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Ivl involucrin decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein CTD PMID:18633435 NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein CTD PMID:18633435 NCBI chr 3:124,406,794...124,442,220
Ensembl chr 3:124,406,794...124,442,209 		JBrowse link
G Krt1 keratin 1 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT1 mRNA		 CTD PMID:18633435 PMID:23566955 NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844 		JBrowse link
G Krt10 keratin 10 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT10 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 protein		 CTD PMID:18633435 PMID:23566955 NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of LGR5 mRNA] CTD PMID:32041402 NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446 		JBrowse link
G Map2 microtubule-associated protein 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809 		JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions
increases expression		 ISO Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein] CTD PMID:25005833 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]		 CTD PMID:24223152 NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]		 CTD PMID:24223152 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Notch1 notch receptor 1 multiple interactions
decreases expression		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of and results in increased activity of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form		 CTD PMID:18633435 PMID:22039516 PMID:22115781 PMID:24223152 PMID:25108166 More... NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531 		JBrowse link
G Notch2 notch receptor 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH2 protein CTD PMID:22039516 NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088 		JBrowse link
G Numb NUMB, endocytic adaptor protein increases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of NUMB protein CTD PMID:25005833 NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354 		JBrowse link
G Pml PML nuclear body scaffold multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA] CTD PMID:18791180 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region multiple interactions
increases expression		 EXP
ISO		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RBPJ mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of RBPJ protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cycloheximide results in decreased expression of RBPJ protein]		 CTD PMID:22302987 PMID:24223152 NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of RELA protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RELA protein] CTD PMID:24223152 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TGFB1 mRNA] CTD PMID:24223152 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TLR4 mRNA] CTD PMID:24223152 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]		 CTD PMID:24223152 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 decreases expression
multiple interactions		 ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein
Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein]		 CTD PMID:25005833 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Traf6 TNF receptor associated factor 6 multiple interactions ISO
EXP		 N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 mRNA]		 CTD PMID:24223152 NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507 		JBrowse link
G Tubb3 tubulin, beta 3 class III multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA] CTD PMID:24929042 NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFA protein] CTD PMID:21843347 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Vil1 villin 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of VIL1 mRNA] CTD PMID:32041402 NCBI chr 9:75,991,141...76,018,860
Ensembl chr 9:75,991,141...76,018,858 		JBrowse link
difloxacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 affects binding ISO difloxacin binds to KCNH2 protein CTD PMID:34058295 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
diflubenzuron term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression EXP Diflubenzuron results in increased expression of CYP1A1 protein CTD PMID:8812189 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 affects binding ISO Diflubenzuron binds to CYP1A2 protein CTD PMID:32278787 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 affects binding ISO Diflubenzuron binds to CYP3A4 protein CTD PMID:32278787 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP Diflubenzuron results in increased expression of CYP3A23-3A1 protein CTD PMID:8812189 NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Diflubenzuron results in increased activity of NR1I2 protein CTD PMID:16565514 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
diflunisal term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Diflunisal results in increased expression of FOS mRNA CTD PMID:12730611 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Il1b interleukin 1 beta increases expression EXP Diflunisal results in increased expression of IL1B mRNA CTD PMID:15135310 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 increases expression EXP Diflunisal results in increased expression of IL6 mRNA CTD PMID:15135310 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression EXP Diflunisal results in increased expression of NOS2 mRNA CTD PMID:15135310 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 increases expression ISO Diflunisal results in increased expression of SLC6A8 mRNA CTD PMID:29901742 NCBI chr  X:151,384,675...151,393,979
Ensembl chr  X:151,384,675...151,393,979 		JBrowse link
G Tnf tumor necrosis factor increases expression EXP Diflunisal results in increased expression of TNF mRNA CTD PMID:15135310 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Ttr transthyretin affects binding
multiple interactions		 ISO Diflunisal binds to TTR protein mutant form
[Diflunisal binds to TTR protein mutant form] which results in decreased susceptibility to Urea; Diflunisal results in increased stability of [TTR protein binds to TTR protein binds to TTR protein binds to TTR protein]		 CTD PMID:17701470 PMID:27093678 NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 decreases activity ISO Diflunisal results in decreased activity of UGT1A1 protein CTD PMID:15593333 NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases glucuronidation ISO UGT1A3 protein results in increased glucuronidation of Diflunisal CTD PMID:15117964 NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 multiple interactions
increases glucuronidation		 ISO Diflunisal inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Diflunisal inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]
UGT2B7 protein alternative form results in increased glucuronidation of Diflunisal; UGT2B7 protein results in increased glucuronidation of Diflunisal		 CTD PMID:8423545 PMID:8517101 PMID:19740398 NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604 		JBrowse link
dolutegravir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 decreases expression ISO dolutegravir results in decreased expression of ALDH1A2 mRNA CTD PMID:34515794 NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107 		JBrowse link
G Cdx1 caudal type homeo box 1 decreases expression ISO dolutegravir results in decreased expression of CDX1 mRNA CTD PMID:34515794 NCBI chr18:54,472,448...54,499,799
Ensembl chr18:54,473,444...54,490,814 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 decreases expression
increases expression		 ISO dolutegravir results in decreased expression of CYP26A1 mRNA
dolutegravir results in increased expression of CYP26A1 mRNA		 CTD PMID:34515794 NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204 		JBrowse link
G Fgf8 fibroblast growth factor 8 increases expression ISO dolutegravir results in increased expression of FGF8 mRNA CTD PMID:34515794 NCBI chr 1:244,584,477...244,590,359
Ensembl chr 1:244,584,652...244,590,359 		JBrowse link
G Hoxb1 homeo box B1 increases expression ISO dolutegravir results in increased expression of HOXB1 mRNA CTD PMID:34515794 NCBI chr10:81,331,507...81,332,928
Ensembl chr10:81,331,507...81,332,836 		JBrowse link
G Hoxb9 homeo box B9 decreases expression ISO dolutegravir results in decreased expression of HOXB9 mRNA CTD PMID:34515794 NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818 		JBrowse link
G Meox1 mesenchyme homeobox 1 decreases expression ISO dolutegravir results in decreased expression of MEOX1 mRNA CTD PMID:34515794 NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660 		JBrowse link
G Mesp2 mesoderm posterior bHLH transcription factor 2 increases expression ISO dolutegravir results in increased expression of MESP2 mRNA CTD PMID:34515794 NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198 		JBrowse link
G Mixl1 Mix paired-like homeobox 1 increases expression ISO dolutegravir results in increased expression of MIXL1 mRNA CTD PMID:34515794 NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065 		JBrowse link
G Tbx6 T-box transcription factor 6 increases expression ISO dolutegravir results in increased expression of TBX6 mRNA CTD PMID:34515794 NCBI chr 1:181,387,851...181,392,762
Ensembl chr 1:181,388,684...181,392,593 		JBrowse link
eliprodil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions ISO eliprodil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] CTD PMID:19583963 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
enzalutamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aadat aminoadipate aminotransferase decreases expression ISO enzalutamide results in decreased expression of AADAT mRNA CTD PMID:29581250 NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression ISO enzalutamide results in decreased expression of ABCC4 mRNA CTD PMID:29581250 NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283 		JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 decreases expression ISO enzalutamide results in decreased expression of ACSM1 mRNA CTD PMID:29581250 NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 affects expression ISO enzalutamide affects the expression of ADAM10 mRNA CTD PMID:30940724 NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 affects expression ISO enzalutamide affects the expression of ADAM17 mRNA CTD PMID:30940724 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639 		JBrowse link
G Adprm ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent decreases expression ISO enzalutamide results in decreased expression of ADPRM mRNA CTD PMID:29581250 NCBI chr10:51,732,073...51,744,635
Ensembl chr10:51,731,993...51,744,635 		JBrowse link
G Aff3 AF4/FMR2 family, member 3 decreases expression ISO enzalutamide results in decreased expression of AFF3 mRNA CTD PMID:29581250 NCBI chr 9:40,399,109...40,856,716
Ensembl chr 9:40,404,375...40,857,247 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO enzalutamide results in decreased expression of ALDH1A3 mRNA CTD PMID:29581250 NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436 		JBrowse link
G Alpk2 alpha-kinase 2 decreases expression ISO enzalutamide results in decreased expression of ALPK2 mRNA CTD PMID:29581250 NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258 		JBrowse link
G Anxa4 annexin A4 affects expression ISO enzalutamide affects the expression of ANXA4 mRNA CTD PMID:30940724 NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161 		JBrowse link
G Aph1a aph-1 homolog A, gamma secretase subunit affects expression ISO enzalutamide affects the expression of APH1A mRNA CTD PMID:30940724 NCBI chr 2:183,437,676...183,443,113
Ensembl chr 2:183,438,434...183,441,955 		JBrowse link
G Aph1b aph-1 homolog B, gamma secretase subunit affects expression ISO enzalutamide affects the expression of APH1B mRNA CTD PMID:30940724 NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243 		JBrowse link
G App amyloid beta precursor protein affects expression ISO enzalutamide affects the expression of APP mRNA CTD PMID:30940724 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Ar androgen receptor multiple interactions
decreases activity
decreases response to substance
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; [enzalutamide co-treated with Niclosamide] results in decreased expression of AR protein; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mRNA alternative form; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein alternative form; [nirogacestat results in increased susceptibility to enzalutamide] which results in decreased expression of AR protein; enzalutamide binds to and results in decreased localization of and results in decreased activity of AR protein; enzalutamide inhibits the reaction [Dihydrotestosterone affects the localization of AR protein]; enzalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; enzalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Niclosamide inhibits the reaction [AR protein alternative form results in decreased susceptibility to enzalutamide]
enzalutamide results in decreased activity of AR protein
AR alternative form results in decreased susceptibility to enzalutamide; AR protein alternative form results in decreased susceptibility to enzalutamide; AR protein results in decreased susceptibility to enzalutamide
enzalutamide results in decreased expression of AR protein; enzalutamide results in decreased expression of AR protein alternative form		 CTD PMID:19359544 PMID:24740322 PMID:24759320 PMID:25908785 PMID:25970160 More... NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding decreases expression ISO enzalutamide results in decreased expression of AZGP1 mRNA CTD PMID:29581250 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO enzalutamide promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] CTD PMID:25970160 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380 		JBrowse link
G Bmpr1b bone morphogenetic protein receptor type 1B decreases expression ISO enzalutamide results in decreased expression of BMPR1B mRNA CTD PMID:29581250 NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368 		JBrowse link
G Casp3 caspase 3 multiple interactions
decreases expression		 ISO enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of CASP3 protein]
enzalutamide results in decreased expression of CASP3 protein		 CTD PMID:32184358 PMID:32805266 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 decreases expression ISO enzalutamide results in decreased expression of CASP8 protein CTD PMID:32805266 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO enzalutamide results in decreased expression of CCNB1 protein CTD PMID:32805266 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Cd46 CD46 molecule increases expression ISO enzalutamide results in increased expression of CD46 protein CTD PMID:30185663 NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of CDC25C mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of CDC25C protein CTD PMID:32184358 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B affects expression ISO enzalutamide affects the expression of CDKN1B mRNA CTD PMID:30940724 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha affects expression ISO enzalutamide affects the expression of CEBPA mRNA CTD PMID:30940724 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412 		JBrowse link
G Crebbp CREB binding protein affects expression ISO enzalutamide affects the expression of CREBBP mRNA CTD PMID:30940724 NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Crisp3 cysteine-rich secretory protein 3 decreases expression ISO enzalutamide results in decreased expression of CRISP3 mRNA CTD PMID:29581250 NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658 		JBrowse link
G Crym crystallin, mu multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of CRYM mRNA] CTD PMID:29581250 NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 decreases expression ISO enzalutamide results in decreased expression of CSGALNACT1 mRNA CTD PMID:29581250 NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression ISO enzalutamide results in decreased expression of DPP4 mRNA CTD PMID:29581250 NCBI chr 3:46,962,243...47,043,870
Ensembl chr 3:46,962,243...47,043,901 		JBrowse link
G Dtx2 deltex E3 ubiquitin ligase 2 affects expression ISO enzalutamide affects the expression of DTX2 mRNA CTD PMID:30940724 NCBI chr12:20,643,289...20,682,908
Ensembl chr12:20,643,297...20,682,885 		JBrowse link
G Dtx3 deltex E3 ubiquitin ligase 3 affects expression ISO enzalutamide affects the expression of DTX3 mRNA CTD PMID:30940724 NCBI chr 7:63,013,769...63,018,431
Ensembl chr 7:63,013,371...63,018,522 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 affects expression ISO enzalutamide affects the expression of DTX4 mRNA CTD PMID:30940724 NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818 		JBrowse link
G Edem3 ER degradation enhancing alpha-mannosidase like protein 3 decreases expression ISO enzalutamide results in decreased expression of EDEM3 mRNA CTD PMID:29581250 NCBI chr13:63,858,282...63,920,538
Ensembl chr13:63,858,716...63,920,523 		JBrowse link
G Eed embryonic ectoderm development multiple interactions
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; enzalutamide promotes the reaction [GSK-2816126 results in decreased expression of EED protein]; GSK-2816126 promotes the reaction [enzalutamide results in decreased expression of EED protein] CTD PMID:32805266 NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974 		JBrowse link
G Efcab12 EF-hand calcium binding domain 12 decreases expression ISO enzalutamide results in decreased expression of EFCAB12 mRNA CTD PMID:29581250 NCBI chr 4:148,869,381...148,892,922
Ensembl chr 4:148,869,387...148,890,560 		JBrowse link
G Ell2 elongation factor for RNA polymerase II 2 decreases expression ISO enzalutamide results in decreased expression of ELL2 mRNA CTD PMID:29581250 NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 decreases expression ISO enzalutamide results in decreased expression of ELOVL7 mRNA CTD PMID:29581250 NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845 		JBrowse link
G Ep300 E1A binding protein p300 affects expression ISO enzalutamide affects the expression of EP300 mRNA CTD PMID:30940724 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Ephb4 EPH receptor B4 affects response to substance
multiple interactions		 ISO EPHB4 protein affects the susceptibility to enzalutamide
enzalutamide promotes the reaction [EPHB4 protein affects the expression of KLK3 protein]; EPHB4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein]		 CTD PMID:32184358 NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314 		JBrowse link
G Epn1 Epsin 1 affects expression ISO enzalutamide affects the expression of EPN1 mRNA CTD PMID:30940724 NCBI chr 1:68,742,491...68,760,507
Ensembl chr 1:68,742,789...68,758,874 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of EZH2 protein
[enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]		 CTD PMID:32805266 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
decreases expression		 ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of FKBP5 mRNA; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of FKBP5 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of FKBP5 mRNA] CTD PMID:32184358 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674 		JBrowse link
G Foxa1 forkhead box A1 affects expression ISO enzalutamide affects the expression of FOXA1 mRNA CTD PMID:30940724 NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188 		JBrowse link
G Galnt11 polypeptide N-acetylgalactosaminyltransferase 11 affects expression ISO enzalutamide affects the expression of GALNT11 mRNA CTD PMID:30940724 NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140 		JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase affects expression ISO enzalutamide affects the expression of GMDS mRNA CTD PMID:30940724 NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961 		JBrowse link
G Gnmt glycine N-methyltransferase decreases expression ISO enzalutamide results in decreased expression of GNMT mRNA CTD PMID:29581250 NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 affects expression ISO enzalutamide affects the expression of GOT1 mRNA CTD PMID:30940724 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 decreases expression ISO enzalutamide results in decreased expression of GREB1 mRNA CTD PMID:29581250 NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 affects expression ISO enzalutamide affects the expression of HES1 mRNA CTD PMID:30940724 NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192 		JBrowse link
G Hnf1b HNF1 homeobox B affects expression ISO enzalutamide affects the expression of HNF1B mRNA CTD PMID:30940724 NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888 		JBrowse link
G Ift172 intraflagellar transport 172 affects expression ISO enzalutamide affects the expression of IFT172 mRNA CTD PMID:30940724 NCBI chr 6:25,081,933...25,121,271
Ensembl chr 6:25,081,980...25,120,860 		JBrowse link
G Ift74 intraflagellar transport 74 affects expression ISO enzalutamide affects the expression of IFT74 mRNA CTD PMID:30940724 NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression ISO enzalutamide results in decreased expression of IGF1 mRNA CTD PMID:29581250 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression ISO enzalutamide results in decreased expression of IGF1R mRNA CTD PMID:29581250 NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases response to substance		 ISO Niclosamide inhibits the reaction [IL6 protein results in decreased susceptibility to enzalutamide] CTD PMID:25970160 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 decreases expression ISO enzalutamide results in decreased expression of IQGAP2 mRNA CTD PMID:29581250 NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279 		JBrowse link
G Itch itchy E3 ubiquitin protein ligase affects expression ISO enzalutamide affects the expression of ITCH mRNA CTD PMID:30940724 NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543 		JBrowse link
G Itgb1bp1 integrin subunit beta 1 binding protein 1 affects expression ISO enzalutamide affects the expression of ITGB1BP1 mRNA CTD PMID:30940724 NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 affects expression ISO enzalutamide affects the expression of JAG1 mRNA CTD PMID:30940724 NCBI chr 3:124,406,794...124,442,220
Ensembl chr 3:124,406,794...124,442,209 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 affects expression ISO enzalutamide affects the expression of JAG2 mRNA CTD PMID:30940724 NCBI chr 6:131,983,056...132,005,359
Ensembl chr 6:131,983,056...132,005,818 		JBrowse link
G Kat2b lysine acetyltransferase 2B affects expression ISO enzalutamide affects the expression of KAT2B mRNA CTD PMID:30940724 NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064 		JBrowse link
G Kdm1a lysine demethylase 1A multiple interactions ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of CRYM mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of KLK3 protein]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mRNA]; KDM1A protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mRNA] CTD PMID:29581250 NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319 		JBrowse link
G Kif5c kinesin family member 5C decreases expression ISO enzalutamide results in decreased expression of KIF5C mRNA CTD PMID:29581250 NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413 		JBrowse link
G Krt19 keratin 19 affects expression ISO enzalutamide affects the expression of KRT19 mRNA CTD PMID:30940724 NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799 		JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase decreases expression ISO enzalutamide results in decreased expression of LCK mRNA CTD PMID:29581250 NCBI chr 5:141,888,319...141,916,992
Ensembl chr 5:141,888,326...141,903,794 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mRNA] CTD PMID:29581250 NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680 		JBrowse link
G LOC498222 similar to specifically androgen-regulated protein decreases expression ISO enzalutamide results in decreased expression of C1ORF116 mRNA CTD PMID:29581250 NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426 		JBrowse link
G Maf MAF bZIP transcription factor decreases expression ISO enzalutamide results in decreased expression of MAF mRNA CTD PMID:29581250 NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365 		JBrowse link
G Maml1 mastermind-like transcriptional coactivator 1 affects expression ISO enzalutamide affects the expression of MAML1 mRNA CTD PMID:30940724 NCBI chr10:34,588,639...34,624,298
Ensembl chr10:34,588,646...34,623,338 		JBrowse link
G Maml3 mastermind-like transcriptional coactivator 3 affects expression ISO enzalutamide affects the expression of MAML3 mRNA CTD PMID:30940724 NCBI chr 2:135,722,585...136,136,975
Ensembl chr 2:135,721,021...136,137,814 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO [enzalutamide co-treated with GSK-2816126] results in increased expression of MAP1LC3B protein modified form CTD PMID:32805266 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 		JBrowse link
G Map2 microtubule-associated protein 2 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA] CTD PMID:29581250 NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809 		JBrowse link
G Mdk midkine affects expression ISO enzalutamide affects the expression of MDK mRNA CTD PMID:30940724 NCBI chr 3:77,901,156...77,903,997
Ensembl chr 3:77,901,158...77,903,130 		JBrowse link
G Mib1 MIB E3 ubiquitin protein ligase 1 affects expression ISO enzalutamide affects the expression of MIB1 mRNA CTD PMID:30940724 NCBI chr18:1,802,519...1,926,988
Ensembl chr18:1,802,519...1,920,689 		JBrowse link
G Mib2 MIB E3 ubiquitin protein ligase 2 affects expression ISO enzalutamide affects the expression of MIB2 mRNA CTD PMID:30940724 NCBI chr 5:166,243,776...166,259,944
Ensembl chr 5:166,243,776...166,259,650 		JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions ISO enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein] CTD PMID:32184358 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Mpc2 mitochondrial pyruvate carrier 2 decreases expression ISO enzalutamide results in decreased expression of BRP44 mRNA CTD PMID:29581250 NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664 		JBrowse link
G Msmb microseminoprotein, beta decreases expression ISO enzalutamide results in decreased expression of MSMB mRNA CTD PMID:33932781 NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression
multiple interactions
affects expression		 ISO enzalutamide results in decreased expression of MYC protein
[enzalutamide co-treated with NVP-BHG712] results in decreased expression of MYC protein; enzalutamide inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]]; enzalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC mRNA]; enzalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of MYC protein]; enzalutamide promotes the reaction [Niclosamide results in decreased expression of MYC protein]; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MYC protein]
enzalutamide affects the expression of MYC mRNA		 CTD PMID:24759320 PMID:25970160 PMID:30940724 PMID:32184358 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Myo1b myosin Ib multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mRNA] CTD PMID:29581250 NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798 		JBrowse link
G Ncstn nicastrin affects expression ISO enzalutamide affects the expression of NCSTN mRNA CTD PMID:30940724 NCBI chr13:84,530,442...84,546,454
Ensembl chr13:84,530,440...84,546,454 		JBrowse link
G Neurl1b neuralized E3 ubiquitin protein ligase 1B affects expression ISO enzalutamide affects the expression of NEURL1B mRNA CTD PMID:30940724 NCBI chr10:16,758,097...16,784,943
Ensembl chr10:16,757,208...16,785,119 		JBrowse link
G Nkap NFKB activating protein affects expression ISO enzalutamide affects the expression of NKAP mRNA CTD PMID:30940724 NCBI chr  X:116,373,031...116,392,677
Ensembl chr  X:116,372,839...116,394,945 		JBrowse link
G Nkx3-1 NK3 homeobox 1 decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of NKX3-1 mRNA
enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mRNA]		 CTD PMID:29581250 PMID:32184358 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nle1 notchless homolog 1 affects expression ISO enzalutamide affects the expression of NLE1 mRNA CTD PMID:30940724 NCBI chr10:67,834,059...67,844,771
Ensembl chr10:67,834,062...67,842,658 		JBrowse link
G Notch1 notch receptor 1 affects response to substance
affects expression
multiple interactions		 ISO NOTCH1 protein affects the susceptibility to enzalutamide
enzalutamide affects the expression of NOTCH1 mRNA
[NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein		 CTD PMID:30940724 NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531 		JBrowse link
G Notch2 notch receptor 2 affects expression ISO enzalutamide affects the expression of NOTCH2 mRNA CTD PMID:30940724 NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088 		JBrowse link
G Notch3 notch receptor 3 affects expression ISO enzalutamide affects the expression of NOTCH3 mRNA CTD PMID:30940724 NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases cleavage
multiple interactions		 ISO enzalutamide results in decreased cleavage of PARP1 protein
[enzalutamide co-treated with GSK-2816126] results in increased cleavage of PARP1 protein; [nirogacestat results in increased susceptibility to enzalutamide] which results in increased cleavage of PARP1 protein; [NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein; enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of PARP1 protein]; EPHB4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein]		 CTD PMID:30940724 PMID:32184358 PMID:32805266 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Perp p53 apoptosis effector related to PMP22 affects expression ISO enzalutamide affects the expression of PERP mRNA CTD PMID:30940724 NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511 		JBrowse link
G Pla2g5 phospholipase A2, group V decreases expression ISO enzalutamide results in decreased expression of PLA2G5 mRNA CTD PMID:29581250 NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658 		JBrowse link
G Plk1 polo-like kinase 1 multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 mRNA; [enzalutamide co-treated with NVP-BHG712] results in decreased expression of PLK1 protein; enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of PLK1 mRNA] CTD PMID:32184358 NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 decreases expression ISO enzalutamide results in decreased expression of PLOD2 mRNA CTD PMID:29581250 NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255 		JBrowse link
G Pofut1 protein O-fucosyltransferase 1 affects expression ISO enzalutamide affects the expression of POFUT1 mRNA CTD PMID:30940724 NCBI chr 3:141,708,618...141,735,558
Ensembl chr 3:141,708,644...141,734,786 		JBrowse link
G Psen1 presenilin 1 affects expression ISO enzalutamide affects the expression of PSEN1 mRNA CTD PMID:30940724 NCBI chr 6:103,323,014...103,375,088
Ensembl chr 6:103,323,120...103,371,650 		JBrowse link
G Psen2 presenilin 2 affects expression ISO enzalutamide affects the expression of PSEN2 mRNA CTD PMID:30940724 NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174 		JBrowse link
G Psenen presenilin enhancer gamma secretase subunit affects expression ISO enzalutamide affects the expression of PSENEN mRNA CTD PMID:30940724 NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:85,814,905...85,816,192 		JBrowse link
G Ptger4 prostaglandin E receptor 4 decreases expression ISO enzalutamide results in decreased expression of PTGER4 mRNA CTD PMID:29581250 NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670 		JBrowse link
G Rbm15 RNA binding motif protein 15 affects expression ISO enzalutamide affects the expression of RBM15 mRNA CTD PMID:30940724 NCBI chr 2:194,945,717...194,954,523
Ensembl chr 2:194,945,974...194,954,703 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region affects expression ISO enzalutamide affects the expression of RBPJ mRNA CTD PMID:30940724 NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353 		JBrowse link
G Rgs2 regulator of G-protein signaling 2 decreases expression ISO enzalutamide results in decreased expression of RGS2 mRNA CTD PMID:29581250 NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385 		JBrowse link
G Rhou ras homolog family member U decreases expression ISO enzalutamide results in decreased expression of RHOU mRNA CTD PMID:29581250 NCBI chr19:51,641,408...51,651,249
Ensembl chr19:51,641,227...51,650,552 		JBrowse link
G Rps19 ribosomal protein S19 affects expression ISO enzalutamide affects the expression of RPS19 mRNA CTD PMID:30940724 NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508 		JBrowse link
G Rps27a ribosomal protein S27a affects expression ISO enzalutamide affects the expression of RPS27A mRNA CTD PMID:30940724 NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 		JBrowse link
G S1pr3 sphingosine-1-phosphate receptor 3 affects expression ISO enzalutamide affects the expression of S1PR3 mRNA CTD PMID:30940724 NCBI chr17:13,781,050...13,794,408
Ensembl chr17:13,781,050...13,794,505 		JBrowse link
G Sel1l SEL1L adaptor subunit of ERAD E3 ubiquitin ligase affects expression ISO enzalutamide affects the expression of SEL1L mRNA CTD PMID:30940724 NCBI chr 6:110,735,450...110,779,695
Ensembl chr 6:110,735,450...110,779,648 		JBrowse link
G Selenop selenoprotein P decreases expression ISO enzalutamide results in decreased expression of SELENOP mRNA CTD PMID:29581250 NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions
decreases expression		 ISO KDM1A protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mRNA] CTD PMID:29581250 NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612 		JBrowse link
G Snw1 SNW domain containing 1 affects expression ISO enzalutamide affects the expression of SNW1 mRNA CTD PMID:30940724 NCBI chr 6:107,095,450...107,119,536
Ensembl chr 6:107,095,457...107,119,536 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 decreases expression ISO enzalutamide results in decreased expression of SOCS2 mRNA CTD PMID:29581250 NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548 		JBrowse link
G Sox9 SRY-box transcription factor 9 affects expression ISO enzalutamide affects the expression of SOX9 mRNA CTD PMID:30940724 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994 		JBrowse link
G Spen spen family transcriptional repressor affects expression ISO enzalutamide affects the expression of SPEN mRNA CTD PMID:30940724 NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811 		JBrowse link
G Spock1 sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 decreases expression ISO enzalutamide results in decreased expression of SPOCK1 mRNA CTD PMID:29581250 NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935 		JBrowse link
G St6galnac1 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 decreases expression ISO enzalutamide results in decreased expression of ST6GALNAC1 mRNA CTD PMID:29581250 NCBI chr10:101,972,656...101,983,053
Ensembl chr10:101,972,668...101,983,053 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases response to substance		 ISO enzalutamide promotes the reaction [Niclosamide results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Niclosamide inhibits the reaction [STAT3 protein results in decreased susceptibility to enzalutamide] CTD PMID:25970160 NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057 		JBrowse link
G Susd5 sushi domain containing 5 affects expression ISO enzalutamide affects the expression of SUSD5 mRNA CTD PMID:30940724 NCBI chr 8:113,996,771...114,036,133
Ensembl chr 8:113,997,362...114,035,861 		JBrowse link
G Suz12 SUZ12 polycomb repressive complex 2 subunit multiple interactions
decreases expression		 ISO [enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]; enzalutamide promotes the reaction [GSK-2816126 results in decreased expression of SUZ12 protein]; GSK-2816126 promotes the reaction [enzalutamide results in decreased expression of SUZ12 protein] CTD PMID:32805266 NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738 		JBrowse link
G Tenm1 teneurin transmembrane protein 1 decreases expression ISO enzalutamide results in decreased expression of TENM1 mRNA CTD PMID:29581250 NCBI chr  X:121,400,466...122,289,877
Ensembl chr  X:121,403,649...122,290,207 		JBrowse link
G Tmcc3 transmembrane and coiled-coil domain family 3 decreases expression
multiple interactions		 ISO enzalutamide results in decreased expression of TMCC3 mRNA
KDM1A protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mRNA]		 CTD PMID:29581250 NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926 		JBrowse link
G Tpd52 tumor protein D52 decreases expression ISO enzalutamide results in decreased expression of TPD52 mRNA CTD PMID:29581250 NCBI chr 2:92,735,246...92,816,079
Ensembl chr 2:92,735,620...92,816,622 		JBrowse link
G Trpm8 transient receptor potential cation channel, subfamily M, member 8 decreases expression ISO enzalutamide results in decreased expression of TRPM8 mRNA CTD PMID:29581250 NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552 		JBrowse link
G Uba52 ubiquitin A-52 residue ribosomal protein fusion product 1 affects expression ISO enzalutamide affects the expression of UBA52 mRNA CTD PMID:30940724 NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807 		JBrowse link
G Ubb ubiquitin B affects expression ISO enzalutamide affects the expression of UBB mRNA CTD PMID:30940724 NCBI chr10:47,247,629...47,249,335
Ensembl chr10:47,245,637...47,249,333 		JBrowse link
G Ubc ubiquitin C affects expression ISO enzalutamide affects the expression of UBC mRNA CTD PMID:30940724 NCBI chr12:31,238,889...31,243,924
Ensembl chr12:31,239,152...31,243,925 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C multiple interactions ISO [enzalutamide co-treated with NVP-BHG712] results in decreased expression of UBE2C mRNA CTD PMID:32184358 NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339 		JBrowse link
G Wdr12 WD repeat domain 12 affects expression ISO enzalutamide affects the expression of WDR12 mRNA CTD PMID:30940724 NCBI chr 9:61,475,498...61,502,584
Ensembl chr 9:61,475,517...61,502,469 		JBrowse link
G Wwtr1 WW domain containing transcription regulator 1 decreases expression ISO enzalutamide results in decreased expression of WWTR1 mRNA CTD PMID:29581250 NCBI chr 2:141,651,159...141,766,919
Ensembl chr 2:141,648,108...141,766,968 		JBrowse link
epoxiconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase decreases expression ISO epoxiconazole results in decreased expression of AASS mRNA CTD PMID:22334560 NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA CTD PMID:29038839 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ABCB1A mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression EXP epoxiconazole results in increased expression of ABCB1B mRNA CTD PMID:25182419 NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ABCC2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA		 CTD PMID:29038839 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of ABCC3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA		 CTD PMID:22334560 PMID:29038839 NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 increases expression ISO epoxiconazole results in increased expression of ABCC4 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283 		JBrowse link
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B increases expression ISO epoxiconazole results in increased expression of ABHD4 mRNA CTD PMID:22334560 NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of ACAA2 mRNA CTD PMID:22334560 NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 increases expression EXP epoxiconazole results in increased expression of ACAD9 mRNA CTD PMID:29038839 NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO epoxiconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA CTD PMID:29038839 NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821 		JBrowse link
G Acly ATP citrate lyase increases expression EXP epoxiconazole results in increased expression of ACLY mRNA CTD PMID:29038839 NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320 		JBrowse link
G Aco1 aconitase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA CTD PMID:29038839 NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391 		JBrowse link
G Acot3 acyl-CoA thioesterase 3 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT3 mRNA CTD PMID:29038839 NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA CTD PMID:29038839 NCBI chr  X:40,073,197...40,123,573
Ensembl chr  X:40,064,810...40,123,559 		JBrowse link
G Acp2 acid phosphatase 2, lysosomal increases expression ISO epoxiconazole results in increased expression of ACP2 mRNA CTD PMID:22334560 NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO epoxiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA CTD PMID:25607892 NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251 		JBrowse link
G Adam11 ADAM metallopeptidase domain 11 increases expression ISO epoxiconazole results in increased expression of ADAM11 mRNA CTD PMID:22334560 NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562 		JBrowse link
G Adh1 alcohol dehydrogenase 1C (class I), gamma polypeptide decreases expression EXP epoxiconazole results in decreased expression of ADH1 mRNA CTD PMID:29038839 NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892 		JBrowse link
G Adss1 adenylosuccinate synthase 1 increases expression ISO epoxiconazole results in increased expression of ADSSL1 mRNA CTD PMID:22334560 NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 decreases expression ISO epoxiconazole results in decreased expression of AHCTF1 mRNA CTD PMID:22334560 NCBI chr13:91,481,932...91,536,391
Ensembl chr13:91,481,936...91,536,391 		JBrowse link
G Ahr aryl hydrocarbon receptor increases expression ISO
EXP		 epoxiconazole results in increased expression of AHR mRNA CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein decreases expression ISO epoxiconazole results in decreased expression of AHSG mRNA CTD PMID:22334560 NCBI chr11:78,117,903...78,145,956
Ensembl chr11:78,117,918...78,145,999 		JBrowse link
G Akap1 A-kinase anchoring protein 1 decreases expression ISO epoxiconazole results in decreased expression of AKAP1 mRNA CTD PMID:22334560 NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896 		JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO epoxiconazole results in decreased expression of AKAP13 mRNA CTD PMID:22334560 NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646 		JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO epoxiconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606 		JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression ISO epoxiconazole results in increased expression of AKR1B7 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of ALDH1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO epoxiconazole results in decreased expression of ALS2 mRNA CTD PMID:22334560 NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737 		JBrowse link
G Anxa10 annexin A10 increases expression ISO epoxiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648 		JBrowse link
G Anxa7 annexin A7 increases expression ISO epoxiconazole results in increased expression of ANXA7 mRNA CTD PMID:22334560 NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA CTD PMID:29038839 NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785 		JBrowse link
G Apoe apolipoprotein E increases expression EXP epoxiconazole results in increased expression of APOE mRNA CTD PMID:28454766 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Apof apolipoprotein F multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA CTD PMID:29038839 NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946 		JBrowse link
G Ar androgen receptor multiple interactions ISO epoxiconazole inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Arg1 arginase 1 decreases expression ISO epoxiconazole results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422 		JBrowse link
G Arl5a ADP-ribosylation factor like GTPase 5A decreases expression ISO epoxiconazole results in decreased expression of ARL5A mRNA CTD PMID:22334560 NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211 		JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 increases expression ISO epoxiconazole results in increased expression of ARPP19 mRNA CTD PMID:22334560 NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO epoxiconazole results in increased expression of ASAH1 mRNA CTD PMID:22334560 NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA CTD PMID:29038839 NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423 		JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO epoxiconazole results in decreased expression of ATF5 mRNA CTD PMID:22334560 NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA CTD PMID:29038839 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177 		JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression ISO epoxiconazole results in increased expression of ATG16L2 mRNA CTD PMID:22334560 NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420 		JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression		 EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA
epoxiconazole results in increased expression of ATM mRNA		 CTD PMID:29038839 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437 		JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 increases expression ISO epoxiconazole results in increased expression of ATP6V0E mRNA CTD PMID:22334560 NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions
increases expression		 EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA
epoxiconazole results in increased expression of ATP8B1 mRNA		 CTD PMID:29038839 NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396 		JBrowse link
G Atxn7l3b ataxin 7-like 3B decreases expression ISO epoxiconazole results in decreased expression of ATXN7L3B mRNA CTD PMID:22334560 NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878 		JBrowse link
G Bace1 beta-secretase 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876 		JBrowse link
G Bace2 beta-secretase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 NCBI chr11:36,707,473...36,789,550
Ensembl chr11:36,707,458...36,789,546 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615 		JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of BHMT2 mRNA CTD PMID:22334560 NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475 		JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO epoxiconazole results in decreased expression of BID mRNA CTD PMID:22334560 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720 		JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA CTD PMID:25607892 NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO epoxiconazole results in decreased expression of C2CD2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739 		JBrowse link
G C4b complement C4B (Chido blood group) decreases expression ISO epoxiconazole results in decreased expression of C4B mRNA CTD PMID:22334560 NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA CTD PMID:25607892 NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225 		JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA CTD PMID:25607892 NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA CTD PMID:25607892 NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648 		JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA CTD PMID:25607892 NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA CTD PMID:25607892 NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752 		JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA CTD PMID:25607892 NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688 		JBrowse link
G Cacna2d3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA CTD PMID:25607892 NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351 		JBrowse link
G Cacnb1 calcium voltage-gated channel auxiliary subunit beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA CTD PMID:25607892 NCBI chr10:82,998,182...83,018,838
Ensembl chr10:82,998,182...83,018,694 		JBrowse link
G Cacnb3 calcium voltage-gated channel auxiliary subunit beta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA CTD PMID:25607892 NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074 		JBrowse link
G Cacng2 calcium voltage-gated channel auxiliary subunit gamma 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA CTD PMID:25607892 NCBI chr 7:109,572,838...109,698,516
Ensembl chr 7:109,574,459...109,697,227 		JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA CTD PMID:25607892 NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341 		JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA CTD PMID:25607892 NCBI chr 1:65,800,820...65,831,165
Ensembl chr 1:65,800,355...65,831,006 		JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA CTD PMID:25607892 NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994 		JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA CTD PMID:25607892 NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050 		JBrowse link
G Capns1 calpain, small subunit 1 increases expression ISO epoxiconazole results in increased expression of CAPNS1 mRNA CTD PMID:22334560 NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795 		JBrowse link
G Cars cysteinyl-tRNA synthetase decreases expression ISO epoxiconazole results in decreased expression of CARS mRNA CTD PMID:22334560 NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941 		JBrowse link
G Casp7 caspase 7 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA CTD PMID:29038839 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Cd36 CD36 molecule increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of CD36 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA		 CTD PMID:22334560 PMID:29038839 NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903 		JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA CTD PMID:25607892 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620 		JBrowse link
G Cd81 Cd81 molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA CTD PMID:25607892 NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660 		JBrowse link
G Cdc34 cell division cycle 34, ubiqiutin conjugating enzyme increases expression ISO epoxiconazole results in increased expression of CDC34 mRNA CTD PMID:22334560 NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA CTD PMID:29038839 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression ISO epoxiconazole results in increased expression of CDS2 mRNA CTD PMID:22334560 NCBI chr 3:119,514,963...119,553,555
Ensembl chr 3:119,515,000...119,553,541 		JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta decreases expression ISO epoxiconazole results in decreased expression of CEBPZ mRNA CTD PMID:22334560 NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600 		JBrowse link
G Ces2c carboxylesterase 2C increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of CES2C mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CES2C mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CES2C mRNA		 CTD PMID:25182419 PMID:29038839 NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790 		JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO epoxiconazole results in increased expression of CES2 mRNA CTD PMID:22334560 NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830 		JBrowse link
G Cggbp1 CGG triplet repeat binding protein 1 decreases expression ISO epoxiconazole results in decreased expression of CGGBP1 mRNA CTD PMID:22334560 NCBI chr11:2,565,629...2,572,869
Ensembl chr11:2,565,484...2,573,031 		JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like increases expression ISO epoxiconazole results in increased expression of CHD1L mRNA CTD PMID:22334560 NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595 		JBrowse link
G Chga chromogranin A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA CTD PMID:25607892 NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398 		JBrowse link
G Chka choline kinase alpha decreases expression ISO epoxiconazole results in decreased expression of CHKA mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516 		JBrowse link
G Chst1 carbohydrate sulfotransferase 1 decreases expression EXP epoxiconazole results in decreased expression of CHST1 mRNA CTD PMID:25182419 NCBI chr 3:78,552,059...78,574,736
Ensembl chr 3:78,548,525...78,574,883 		JBrowse link
G Cmahp cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene decreases expression ISO epoxiconazole results in decreased expression of CMAH mRNA CTD PMID:22334560 NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA CTD PMID:29038839 NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression ISO epoxiconazole results in increased expression of CREG1 mRNA CTD PMID:22334560 NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308 		JBrowse link
G Crp C-reactive protein increases expression ISO epoxiconazole results in increased expression of CRP mRNA CTD PMID:22334560 NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178 		JBrowse link
G Ctsd cathepsin D increases expression ISO epoxiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488 		JBrowse link
G Ctse cathepsin E multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA CTD PMID:29038839 NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502 		JBrowse link
G Ctsl cathepsin L increases expression ISO epoxiconazole results in increased expression of CTSL mRNA CTD PMID:22334560 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548 		JBrowse link
G Ctso cathepsin O increases expression ISO epoxiconazole results in increased expression of CTSO mRNA CTD PMID:22334560 NCBI chr 2:167,230,407...167,254,761
Ensembl chr 2:167,230,330...167,253,702 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO epoxiconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA CTD PMID:28454766 NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases expression EXP epoxiconazole results in increased expression of CYP11B2 mRNA CTD PMID:28454766 NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO
EXP		 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA		 CTD PMID:25233012 PMID:25607892 NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity		 EXP
ISO		 epoxiconazole results in increased expression of CYP1A1 mRNA
[epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA
epoxiconazole results in increased activity of CYP1A1 protein
epoxiconazole results in increased expression of CYP1A1 mRNA; epoxiconazole results in increased expression of CYP1A1 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [epoxiconazole results in increased expression of CYP1A1 mRNA]; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein		 CTD PMID:25182419 PMID:25233012 PMID:29038839 PMID:29294346 PMID:32194361 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression
multiple interactions
increases activity		 ISO
EXP		 epoxiconazole results in increased expression of CYP2B10 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA
epoxiconazole results in increased activity of CYP2B1 protein
epoxiconazole results in increased expression of CYP2B1 mRNA		 CTD PMID:22334560 PMID:23970803 PMID:25182419 PMID:29038839 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052 		JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 increases expression EXP epoxiconazole results in increased expression of CYP2B15 mRNA CTD PMID:25182419 NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of CYP2B2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP2B2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B2 mRNA		 CTD PMID:29038839 NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression
multiple interactions		 ISO epoxiconazole results in increased expression of CYP2B9 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein		 CTD PMID:22334560 PMID:23970803 PMID:29294346 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression EXP epoxiconazole results in increased expression of CYP2C11 mRNA CTD PMID:29038839 NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066 		JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 increases expression ISO epoxiconazole results in increased expression of CYP2C55 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238 		JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases expression
decreases expression		 EXP
ISO		 epoxiconazole results in increased expression of CYP2C6V1 mRNA
epoxiconazole results in decreased expression of CYP2C19 protein		 CTD PMID:25182419 PMID:32194361 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA CTD PMID:29038839 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions		 EXP
ISO		 epoxiconazole results in increased expression of CYP3A2 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 protein
epoxiconazole results in increased expression of CYP3A4 mRNA; epoxiconazole results in increased expression of CYP3A4 protein
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA		 CTD PMID:29038839 PMID:29294346 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression
multiple interactions
increases activity		 EXP epoxiconazole results in increased expression of CYP3A23-3A1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein; [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein
epoxiconazole results in increased activity of CYP3A23-3A1 protein		 CTD PMID:25182419 PMID:29038839 NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 increases expression EXP epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348 		JBrowse link
G Cyp51 cytochrome P450, family 51 decreases activity ISO epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression		 EXP
ISO		 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA
epoxiconazole results in decreased expression of CYP7A1 mRNA		 CTD PMID:29038839 PMID:32194361 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression ISO epoxiconazole results in decreased expression of DBT mRNA CTD PMID:22334560 NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609 		JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA CTD PMID:25607892 NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740 		JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression ISO epoxiconazole results in increased expression of DDOST mRNA CTD PMID:22334560 NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413 		JBrowse link
G Ddx46 DEAD-box helicase 46 decreases expression ISO epoxiconazole results in decreased expression of DDX46 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:8,944,197...8,988,476
Ensembl chr17:8,944,454...8,988,439 		JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO epoxiconazole results in decreased expression of DDX6 mRNA CTD PMID:22334560 NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405 		JBrowse link
G Dexi Dexi homolog decreases expression ISO epoxiconazole results in decreased expression of DEXI mRNA CTD PMID:22334560 NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 NCBI chr12:33,055,784...33,070,400
Ensembl chr12:33,055,263...33,070,387 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression EXP epoxiconazole results in increased expression of DLAT mRNA CTD PMID:29038839 NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA CTD PMID:25607892 NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA CTD PMID:25607892 NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153 		JBrowse link
G Dlgap3 DLG associated protein 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA CTD PMID:25607892 NCBI chr 5:139,491,972...139,562,625
Ensembl chr 5:139,492,947...139,562,625 		JBrowse link
G Dlgap4 DLG associated protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA CTD PMID:25607892 NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490 		JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression ISO epoxiconazole results in decreased expression of DMGDH mRNA CTD PMID:22334560 NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528 		JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 decreases expression ISO epoxiconazole results in decreased expression of DNAI1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression EXP epoxiconazole results in increased expression of DNAJB1 mRNA CTD PMID:29038839 NCBI chr19:24,522,717...24,526,458
Ensembl chr19:24,522,717...24,526,458 		JBrowse link
G Doc2a double C2 domain alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA CTD PMID:25607892 NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030 		JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO epoxiconazole results in increased expression of DPAGT1 mRNA CTD PMID:22334560 NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087 		JBrowse link
G Dpp10 dipeptidyl peptidase like 10 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA CTD PMID:25607892 NCBI chr13:34,584,420...36,269,619
Ensembl chr13:34,595,868...36,269,292 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA CTD PMID:25607892 NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA CTD PMID:25607892 NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982 		JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression ISO epoxiconazole results in increased expression of DUSP3 mRNA CTD PMID:22334560 NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962 		JBrowse link
G Egf epidermal growth factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA CTD PMID:25607892 NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA CTD PMID:25607892 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Egr1 early growth response 1 decreases expression EXP epoxiconazole results in decreased expression of EGR1 mRNA CTD PMID:28454766 NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP epoxiconazole results in decreased expression of EHD1 mRNA CTD PMID:28454766 NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA CTD PMID:29038839 NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions		 EXP epoxiconazole results in increased expression of EIF2AK3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA		 CTD PMID:29038839 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 decreases expression ISO epoxiconazole results in decreased expression of EIF4G2 mRNA CTD PMID:22334560 NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588 		JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO epoxiconazole results in increased expression of ELOVL1 mRNA CTD PMID:22334560 NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958 		JBrowse link
G Enho energy homeostasis associated decreases expression ISO epoxiconazole results in decreased expression of ENHO mRNA CTD PMID:22334560 NCBI chr 5:56,800,980...56,802,777
Ensembl chr 5:56,800,980...56,802,777 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression ISO epoxiconazole results in increased expression of ENTPD5 mRNA CTD PMID:22334560 NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA CTD PMID:29038839 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
multiple interactions		 ISO
EXP		 epoxiconazole results in increased expression of EPHX1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA		 CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235 		JBrowse link
G Ephx2 epoxide hydrolase 2 decreases expression ISO epoxiconazole results in decreased expression of EPHX2 mRNA CTD PMID:22334560 NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA CTD PMID:25607892 NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA CTD PMID:25607892 NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA CTD PMID:25607892 NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963 		JBrowse link
G Etfa electron transfer flavoprotein subunit alpha decreases expression ISO epoxiconazole results in decreased expression of ETFA mRNA CTD PMID:22334560 NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969 		JBrowse link
G Etnppl ethanolamine-phosphate phospho-lyase decreases expression ISO epoxiconazole results in decreased expression of ETNPPL mRNA CTD PMID:22334560 NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212 		JBrowse link
G Exosc8 exosome component 8 increases expression ISO epoxiconazole results in increased expression of EXOSC8 mRNA CTD PMID:22334560 NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928 		JBrowse link
G F10 coagulation factor X increases expression ISO epoxiconazole results in increased expression of F10 mRNA CTD PMID:22334560 NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141 		JBrowse link
G F5 coagulation factor V decreases expression ISO epoxiconazole results in decreased expression of F5 mRNA CTD PMID:22334560 NCBI chr13:76,513,463...76,583,106
Ensembl chr13:76,513,255...76,582,317 		JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO epoxiconazole results in decreased expression of FAH mRNA CTD PMID:22334560 NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505 		JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression ISO epoxiconazole results in increased expression of FAM114A1 mRNA CTD PMID:22334560 NCBI chr14:43,275,693...43,346,227
Ensembl chr14:43,275,701...43,346,174 		JBrowse link
G Fam168a family with sequence similarity 168, member A decreases expression ISO epoxiconazole results in decreased expression of FAM168A mRNA CTD PMID:22334560 NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA CTD PMID:29038839 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Fasn fatty acid synthase increases expression EXP epoxiconazole results in increased expression of FASN mRNA CTD PMID:29038839 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fez2 fasciculation and elongation protein zeta 2 increases expression ISO epoxiconazole results in increased expression of FEZ2 mRNA CTD PMID:22334560 NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626 		JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of FGF1 mRNA CTD PMID:22334560 NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA CTD PMID:25607892 NCBI chr  X:147,240,239...147,278,057
Ensembl chr  X:147,240,301...147,278,050 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA CTD PMID:25607892 NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911 		JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 increases expression ISO epoxiconazole results in increased expression of G3BP2 mRNA CTD PMID:22334560 NCBI chr14:15,932,356...16,020,555
Ensembl chr14:15,987,417...16,020,548 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA CTD PMID:25607892 NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844 		JBrowse link
G Gabrb1 gamma-aminobutyric acid type A receptor subunit beta1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA CTD PMID:25607892 NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO epoxiconazole results in increased expression of GADD45B mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046 		JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO epoxiconazole results in increased expression of GCH1 mRNA CTD PMID:22334560 NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA CTD PMID:25607892 NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209 		JBrowse link
G Ghr growth hormone receptor decreases expression ISO epoxiconazole results in decreased expression of GHR mRNA CTD PMID:22334560 NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735 		JBrowse link
G Glrx glutaredoxin increases expression ISO epoxiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680 		JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO epoxiconazole results in increased expression of GLRX5 mRNA CTD PMID:22334560 NCBI chr 6:123,988,169...123,998,545
Ensembl chr 6:123,988,134...123,998,545 		JBrowse link
G Gls glutaminase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900 		JBrowse link
G Gls2 glutaminase 2 decreases expression ISO epoxiconazole results in decreased expression of GLS2 mRNA CTD PMID:22334560 NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426 		JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression ISO epoxiconazole results in decreased expression of GLUD1 mRNA CTD PMID:22334560 NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957 		JBrowse link
G Gpc1 glypican 1 decreases expression EXP epoxiconazole results in decreased expression of GPC1 mRNA CTD PMID:28454766 NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP epoxiconazole results in increased expression of GPD1 mRNA CTD PMID:29038839 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877 		JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression ISO epoxiconazole results in increased expression of GPX4 mRNA CTD PMID:22334560 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA CTD PMID:25607892 NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510 		JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA CTD PMID:25607892 NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979 		JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA CTD PMID:25607892 NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645 		JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA CTD PMID:25607892 NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA CTD PMID:25607892 NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA CTD PMID:25607892 NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279 		JBrowse link
G Grip1 glutamate receptor interacting protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA CTD PMID:25607892 NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7:54,934,250...55,592,273 		JBrowse link
G Grn granulin precursor decreases expression ISO epoxiconazole results in decreased expression of GRN mRNA CTD PMID:22334560 NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP epoxiconazole results in increased expression of GSR mRNA CTD PMID:25182419 NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798 		JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472 		JBrowse link
G Gsta6 glutathione S-transferase alpha 6 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 9:23,743,262...23,806,260
Ensembl chr 9:23,744,288...23,801,131 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP
ISO		 epoxiconazole results in increased expression of GSTM1 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression EXP
ISO		 epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961 		JBrowse link
G Gstm4 glutathione S-trans